Multifunctional Nanoparticles for Theranostics of Protein Misfolding Diseases: A Systematic Review
Journal of Biomedical Materials Research Part B: Applied Biomaterials · 2026-06 · 114 (6)
DOI: 10.1002/jbm.b.70106 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Biomedical Materials Research Part B: Applied Biomaterials, online erschienen am 04.06.2026. Verfasst von Huraira Tariq und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering and Sciences, School of Mechanical and Manufacturing Engineering, National University of Sciences and Technology…. Hauptthemen laut MEDLINE: Proteostasis Deficiencies, Nanoparticles, Theranostic Nanomedicine. Die Arbeit nennt 103 Literaturangaben.
Abstract (Originalsprache)
Protein misfolding disorders such as Parkinson's disease, Alzheimer's disease, islet amyloidosis, and several other diseases (amyloidosis) are characterized by the pathological accumulation of misfolded proteins that aggregate into toxic oligomers and fibrils. These misfolded proteins trigger oxidative stress, disrupt cellular homeostasis, and ultimately lead to tissue dysfunction. Overcoming the limitations of conventional strategies, multifunctional nanoparticles have emerged as a promising solution for simultaneously detecting, monitoring, and modulating pathogenic protein aggregates, offering a synergistic approach to addressing the multifaceted challenges of protein misfolding diseases. This systematic review examined 85 relevant studies published between 2010 and 2025, identified through PubMed searches. Only experimental studies reporting multifunctional or dual‐functional nanoparticles for the theranostics of protein misfolding disorders were included. Data were narratively synthesized according to nanoparticle type, biomedical function, and therapeutic or diagnostic outcomes. The main findings suggest that multifunctional nanoparticles, including metallic, lipid, polymeric, carbon, silica, and hydrogel nanoparticles, can enable real‐time monitoring, enhance imaging resolution, improve delivery of anti‐amyloidogenic drugs, and mitigate oxidative stress and neuro‐inflammation. Some strategies demonstrate potential to cross the blood–brain barrier, selectively bind amyloid aggregates, and provide synergistic theranostic effects. Among these, magnetic nanoparticles are superior because they possess intrinsic diagnostic capabilities and can be used for therapy simultaneously, eliminating the need for additional diagnostic agents. Their multifunctional nature offers several advantages for precision nano‐theranostics in managing amyloidosis, though further translational studies are essential to establish scalability, safety, and long‐term clinical applicability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Engineering and Sciences, School of Mechanical and Manufacturing Engineering, National University of Sciences and Technology, Islamabad, Pakistan.
ORCID-Profile: Huraira Tariq, Shahrukh Khan, Hadiqa Shahid, Tehreem Sohail, Aneeqa Noor
Zitieren
APA
Tariq, H., Khan, S., Shahid, H., Sohail, T., & Noor, A. (2026). Multifunctional Nanoparticles for Theranostics of Protein Misfolding Diseases: A Systematic Review. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 114(6). https://doi.org/10.1002/jbm.b.70106
Vancouver
Tariq H, Khan S, Shahid H, Sohail T, Noor A. Multifunctional Nanoparticles for Theranostics of Protein Misfolding Diseases: A Systematic Review. Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2026;114(6). doi:10.1002/jbm.b.70106
BibTeX
@article{Tariq2026,
author = {Tariq, Huraira and Khan, Shahrukh and Shahid, Hadiqa and Sohail, Tehreem and Noor, Aneeqa},
title = {Multifunctional Nanoparticles for Theranostics of Protein Misfolding Diseases: A Systematic Review},
journal = {Journal of Biomedical Materials Research Part B: Applied Biomaterials},
year = {2026},
volume = {114},
number = {6},
doi = {10.1002/jbm.b.70106}
}
EUVIMED